Parhelia and Sirona Dx Partner to Advance the Next Generation of Scalable Spatial Biology Research
Partnership combines Sirona Dx‘s technology-agnostic spatial biology expertise with Parhelia‘s Spatial Station platform to improve reproducibility, increase throughput, and reduce costs across spatial biology workflows. ASHLAND, Ore. and PORTLAND, Ore., July 21, 2026 /PRNewswire/ — Parhelia Biosciences and Sirona Dx today announced a strategic partnership aimed at advancing the adoption of spatial biology in translational research, clinical trials, and precision health initiatives. While spatial biology technologies have transformed researchers’ ability to understand tissue architecture and cellular interactions, many […]
Multiplex IHC Assay Development Guide
Multiplex immunohistochemistry (mIHC) enables the identification of different immune cell subsets, their activation state, and their spatial distribution in the tumor microenvironment (TME) allowing maximum data collection from precious clinical samples. In practice, the simultaneous detection of multiple protein biomarkers on a single tissue section can be challenging therefore in a clinical setting it is essential to implement a rigorous optimization and validation process to ensure the assay can be trusted and is fit for […]
Nucleai and Sirona Dx Partner to Deliver an Integrated Spatial Proteomics Solution for Pharma Drug Development
New integrated offering enables pharma sponsors to capture and translate the full value of spatial proteomics data from tissue to insight in a single engagement. TEL AVIV, Israel–(BUSINESS WIRE)–Nucleai, a leader in AI-powered spatial biology analytics, and Sirona Dx, a Technical CRO, specialized in spatial biology and single-cell services, today announced a strategic partnership to deliver a fully integrated and scalable spatial proteomics solution for pharmaceutical and biotechnology companies. Spatial proteomics platforms are generating increasingly […]
Navigating FDA Guidance for ADC Development with Spatial Biology
by Andrew Brown, PhD Antibody-drug conjugates have moved from concept to a proven therapeutic class. With more than 15 FDA-approved ADCs and a pipeline of over 100 candidates in active clinical development, ADCs represent one of the fastest-growing segments of the oncology pipeline. The momentum is driven by a simple but powerful idea: deliver cytotoxic payloads directly to tumor cells while sparing healthy tissue. The clinical impact is already reshaping how we think about target […]
Hamamatsu Photonics and Sirona Dx (SDX) Announce Strategic Partnership to Expand Technology Access Program
BRIDGEWATER, N.J., April 11, 2025 /PRNewswire/ — Hamamatsu Photonics, a global leader in whole slide imaging and spatial proteomics solutions, is pleased to announce a strategic partnership with Sirona Dx (SDX) as its Technology Access Partner. This collaboration will streamline the technology evaluation process by providing customers with access to deep spatial biology expertise within a GCLP / CLIA accredited laboratory for imaging, staining, and bioinformatics analysis, removing barriers to adoption. Enhancing Technology Evaluation in Spatial Proteomics […]
Nature Methods has crowned Spatial Proteomics as the Method of the Year!
At Sirona Dx, we’re proud to have been at the forefront of this revolutionary field for over six years. In collaboration with leading platform innovators like Standard BioTools, Akoya, Lunaphore, Nanostring, and most recently, Hamamatsu, we’ve continually pushed the boundaries of spatial biology. From platform selection to assay development and advanced analysis, our dedicated team remains steadfast in delivering cutting-edge solutions and services for our clients. Here’s to a future of innovation and discovery! 💡 […]